Yahoofinance, Digital Transformation, Digital Transformation

Yahoofinance, Digital Transformation

BUDGET 2021: Creating transformation opportunities for a better tomorrow

What was important in the blueprint of Budget 2021 was the clear message of urgently getting Singapore Inc back on the path of transformation, innovation and scaling up. #YahooFinance

17/2/2021 1:45:00 PM

What was important in the blueprint of Budget 2021 was the clear message of urgently getting Singapore Inc back on the path of transformation, innovation and scaling up. YahooFinance

While Singapore’s ‘Emerging Stronger Together’ Budget 2021 carries few major surprises, it sets the tone for the country’s re-emergence from the pandemic as a global hub for technology, finance and enterprise.

AdEine Investition von € 250 in diese Unternehmen könnte Ihnen ein zweites Einkommen bringenReutersSouth Korea bourse to review Hyundai officials' trades after Apple deal reportsSouth Korea's stock exchange will begin a review next week to examine if executives of Hyundai Motor may have used undisclosed information to trade shares following reports of a tie-up with Apple, an exchange spokeswoman said. Shares of Hyundai jumped 21% between its initial confirmation of talks on autonomous vehicles between the two firms and an announcement last week that the talks were off. Earlier on Wednesday, top financial regulator Eun Sung-soo, the chairman of the Financial Services Commission (FSC), told a parliament committee the exchange review could begin next week.

Man, 86, jailed for molesting 11-year-old girl and woman on public buses Man in China almost dies after inserting live eel into his rectum to cure constipation 130 new locally transmitted COVID-19 cases in Singapore, including 48 unlinked infections

4 minutes agoGlobeNewswireMotor Vehicle Engine, Power Train & Parts Global Market Report 2021: COVID 19 Impact and Recovery to 2030Major companies in the motor vehicle engine, power train, & parts market include Honda; BMW; Toyota; Mercedes-Benz and Ford. The global motor vehicle engine, power train & parts market is expected to grow from $806.New York, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Motor Vehicle Engine, Power Train & Parts Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https://www.reportlinker.com/p06025340/?utm_source=GNW 94 billion in 2020 to $846.39 billion in 2021 at a compound annual growth rate (CAGR) of 4.9%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $1135.99 billion in 2025 at a CAGR of 8%.The motor vehicle engine, power train, & parts market consists of sales of motor vehicle engine, power train, & parts and related services by entities (organizations, sole traders and partnerships) that produce and/or rebuild motor vehicle transmissions and power train parts. The motor vehicle engine, power train & parts market is segmented into vehicle engine and engine parts and power train and power train parts.Asia Pacific was the largest region in the global motor vehicle engine, power train & parts market, accounting for 48% of the market in 2020. Western Europe was the second largest region accounting for 22% of the global motor vehicle engine, power train & parts market. Africa was the smallest region in the global motor vehicle engine, power train & parts market.Motor vehicle parts manufacturers are using IoT to reduce unscheduled downtimes, thereby increasing operational efficiency. IoT is a system of "connected devices" with the ability to collect and exchange data over a network without any human intervention and assistance. IoT helps motor vehicle parts manufacturers to increase their efficiency by providing real-time information about production processes. In addition, IoT can be used by automobile parts manufacturers to obtain wear and tear data that can prevent equipment failures. For instance, German car parts maker Robert Bosch signed an agreement with software company SAP to connect its manufacturing machinery, tools and vehicles to SAP’s back-end software. This IoT technology uses SAP’s real-time database HANA to monitor and support the production of automobile parts. The global automotive IoT market is expected to reach 106.32 billion by 2023. According to IDC and SAP, 60 % of global manufacturers use analytics data tracked from IoT connected devices to analyse the manufacturing processes.The outbreak of Coronavirus disease (COVID-19) has acted as a massive restraint on the motor vehicle engine, power train & parts market in 2020 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID 19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty in breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China and spread globally including Western Europe, North America and Asia. Transportation manufacturers depend heavily on supply of parts and components from different countries across the globe. As many governments restricted the movement of goods across countries, manufacturers had to halt production due to lack of parts and components. Also, sales of new automobiles decreased significantly due to decline in consumer demand as many countries impose lockdowns. The outbreak is expected to continue to have a negative impact on businesses throughout 2020 and into 2021. However, it is expected that the motor vehicle engine, power train & parts market will recover from the shock across the forecast period as it is a ’black swan’ event and not related to ongoing or fundamental weaknesses in the market or the global economyThe motor vehicle engine, power train & part market is aided by stable economic growth forecasted in many developed and developing countries. The International Monetary Fund (IMF) predicts that the global GDP growth will be 3.3% in 2020 and 3.4% in 2021. Recovering commodity prices, after a significant decline in the historic period is further expected to aid the market growth. Developed economies are also expected to register stable growth during the forecast period. Additionally, emerging markets are expected to continue to grow slightly faster than the developed markets in the forecast period. Stable economic growth is expected to increase investments in the end user markets, thereby driving the market during forecast period. Read the full report: https://www.reportlinker.com/p06025340/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

5 minutes agoGlobeNewswireIn-vitro Diagnostics (IVD) Market to Reach $118.5 Billion by 2027, Growing at a CAGR of 7% From 2020 with COVID-19 Impact- Meticulous Research® AnalysisIn-vitro Diagnostics Market (IVD Market) by Product & Solution (Consumables, Systems, Software & Services), Technology (ELISA, Rapid Tests, PCR, Microbiology), Application (Infectious Diseases, Oncology), End User (Hospitals, Diagnostic Laboratories) – Forecast to 2027London, Feb. 17, 2021 (GLOBE NEWSWIRE) -- The epidemiological burden of infectious diseases worldwide has increased in the past few years. Various infections such as Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), Ebola, Chikungunya, Avian flu, Swine flu, and Zika have emerged. The recent outbreak of the coronavirus (COVID-19) disease is a devastating example. Due to this global crisis of increasing outbreaks of infectious diseases, there is a rising need for early disease diagnosis to help medical professionals and patients make important medical decisions regarding care and support. In turn, this need has boosted the demand for diagnostic kits and assays. Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4858 In efforts to deliver effective diagnostic reagents, manufacturers have started developing tests that require minimal time for testing and are more advanced than the tests currently available. In its latest publication, titled “In-vitro Diagnostics Market (IVD Market) by Product & Solution (Consumables, Systems, Software & Services), Technology (ELISA, Rapid Tests, PCR, Microbiology), Application (Infectious Diseases, Oncology), End User (Hospitals, Diagnostic Laboratories) – Forecast to 2027”, Meticulous Research® states that the in-vitro diagnostics market is expected to grow at a CAGR of 7% from 2020 to 2027 to reach $118.5 billion by 2027. The growth in the in-vitro diagnostics market is mainly attributed to the increasing global prevalence of acute and chronic infectious diseases associated with the rising geriatric population, growing awareness regarding early disease diagnosis, a shift in the focus from centralized testing to point-of-care testing, and the emergence of the COVID-19 pandemic. Moreover, emerging economies, the development of condition-specific markers and tests, and advances in genomics and proteomics offer significant growth opportunities for the players operating in the IVD market. On the other hand, technical requirements and regulatory processes for high/moderate complexity tests hinder this market's growth to a certain extent. To provide efficient analysis, Meticulous Research® has segmented the in-vitro diagnostics market based on product & solution, technology, application, end-user, and geography. Based on product and solution, the in-vitro diagnostics (IVD) market is broadly segmented into kits & reagents, instruments, and software and services. In 2020, the kits & reagents segment accounted for the largest share of the overall in-vitro diagnostics (IVD) market. The large share of this segment is primarily attributed to the frequent use of assays & kits in the detection of various chronic diseases, commercial availability of a diverse range of reagents & consumables for various diseases diagnosis, increase in the volume of testing for infectious diseases such as COVID-19 and influenza, and rise in demand of molecular and immunoassay reagents across the globe. Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=4858 Based on technology, the in-vitro diagnostics (IVD) market is segmented into immunoassay/ immunochemistry, molecular diagnostics, biochemistry/clinical chemistry, microbiology, hematology, coagulation/hemostasis, urinalysis, and other technologies, which include hybridization and loop mediated amplification. In 2020, the immunoassay/ immunochemistry segment accounted for the largest share of the overall in-vitro diagnostics (IVD) market due to the increase in the prevalence of infectious diseases, the exponential rise in the number of diagnostic tests for COVID-19, and rise in the number of approvals and emergency use authorizations of COVID-19 test kits & reagents. However, the molecular diagnostics segment is expected to grow at the fastest CAGR during the forecast period due to rising awareness of personalized medicine and companion diagnostics, advancements in molecular techniques, rising focus of market players on the development of diagnostic NGS kits & reagents, and rising penetration of cutting-edge clinical laboratory technologies. Based on application, the in-vitro diagnostics (IVD) market is segmented into infectious diseases, oncology, cardiology, endocrinology, diabetes, nephrology, and other applications, which include toxicology, gastrology, neonatal, genetic, and neurological disorders. In 2020, the infectious diseases segment was estimated to account for the largest share of the overall in-vitro diagnostics (IVD) market. The large share of this segment is primarily attributed to the recent regulatory approvals, product launches, increase in the availability of COVID-19 test kits across the globe, and the growth of the infectious diseases segment. However, the oncology segment is expected to grow at the fastest CAGR during the forecast period due to the adoption of various strategies for increasing access to new diagnostic technologies in oncology by IVD manufacturers, the growing influx of new products for cancer diagnosis owing to the rising prevalence of cancer, and growing field of personalized medicine in oncology. Quick Buy – IVD Market Research Report: https://www.meticulousresearch.com/Checkout/14280305 Based on the end user, the in-vitro diagnostics (IVD) market is broadly segmented into diagnostics reference laboratories, hospitals and clinics, home healthcare, and other end users, including nursing homes, academic and research institutes, forensic laboratories, and transfusion laboratories. In 2020, the diagnostics reference laboratories segment accounted for the largest share of the overall in vitro diagnostics (IVD) market. The large share of this segment is primarily attributed to the rising numbers of samples shared with laboratories for analysis, rising laboratory automation, availability of well-equipped systems, presence of skilled laborers, rise in the number of patient volume owing to the emergence of various infectious diseases, and government initiatives to support the technological advancements of laboratories. Based on geography, the global IVD) market is categorized into five major regions: North America, Europe, Asia- Pacific, Latin America, and the Middle East & Africa, with a further analysis of major countries in these regions. In 2020, North America accounted for the largest share of the global IVD market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The rising prevalence of various infectious diseases, the growing healthcare sector, increasing awareness regarding early disease diagnosis, higher adoption for advanced innovative diagnostic products, and increasing funding activities coupled with novel advanced diagnostic technologies contribute to the growth. Some of the key players operating in the global IVD market are Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), DiaSorin S.p.A. (Italy), Ortho Clinical Diagnostics (U.S.), Siemens Healthcare GmbH (Germany), Sysmex Corporation (Japan), and QIAGEN N.V. (Netherlands) among others. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/ivd-market-4858 Scope of the Report: In-vitro Diagnostics Market, by Product & Solution ConsumablesSystemsSoftware & Services In-vitro Diagnostics Market, by Technology Immunoassay/ Immunochemistry Enzyme-linked Immunosorbent Assay (ELISA)RadioimmunoassayRapid TestsWestern BlottingEnzyme-linked Immunospot Assays Biochemistry/Clinical Chemistry Molecular DiagnosticsPolymerase Chain Reaction (PCR)Isothermal Nucleic Acid Amplification TechnologyMicroarrayHybridizationDNA Sequencing & Next-generation Sequencing MicrobiologyHematologyCoagulation/HemostasisUrinalysisOther Technologies* (*Other Technologies Include Anatomical Pathology, Histochemistry, and Others.) In-vitro Diagnostics Market, by Application Infectious DiseasesOncologyEndocrinologyDiabetesCardiologyNephrologyOther Applications* (*Other Applications Comprise Genetic and Neurological Disorders, Autoimmune Disorders, Hepatology, and Congenital Disorders.) In-vitro Diagnostics Market, by End User Diagnostic Reference LaboratoriesHospitals & ClinicsHome HealthcareOther End Users* (*Other End-users Comprise Nursing Homes, Academic and Research Institutes, and Transfusion Laboratories.) In-vitro Diagnostics Market, by Geography North America U.S.Canada Europe GermanyU.K.FranceItalySpainRest of Europe (RoE) Asia-Pacific (APAC) ChinaJapanIndiaRest of APAC (RoAPAC) Latin AmericaMiddle East & Africa Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4858 Amidst this crisis, Meticulous Research® is continuously assessing the impact of the COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here- https://www.meticulousresearch.com/custom-research Related Reports- In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analyte Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory) - Global Forecast to 2027 https://www.meticulousresearch.com/product/in-vitro-diagnostic-reagents-market-5110 Infectious Disease Diagnostics Market by Product and Solution (Consumables, System, Software and Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Global Forecast to 2027 https://www.meticulousresearch.com/product/infectious-disease-diagnostics-market-4976 Influenza Diagnostics Market by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, Research Institutes) - Global Forecast to 2027 https://www.meticulousresearch.com/product/influenza-diagnostics-market-5099 Immunoassay Market by Product (Kits and Reagents, Analyzers, Software), Platform (Chemiluminescence, Radioimmunoassays) Application (Infectious Diseases, Cardiology), End User (Hospitals, Academic Laboratories), and Geography - Global Forecast to 2025 https://www.meticulousresearch.com/product/immunoassay-market-4982 About Meticulous Research® Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to detail. With meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact:Mr. Khushal BombeMeticulous Research®Direct Lines: +1-646-781-8004 (North America)+44-203-868-8738 (Europe)+91 744-7780008 (Asia-Pacific)Email- sales@meticulousresearch.comVisit Our Website: https://www.meticulousresearch.com/Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-researchContent Source: https://www.meticulousresearch.com/pressrelease/198/ivd-market-2027 CONTACT: Mr. Khushal Bombe Meticulous Research® Email- sales@meticulousresearch.com headtopics.com

Read more: Yahoo Singapore »

2021 Tokyo Olympic Games | Yahoo Singapore